COVID-19 Vaccine Administration Booster Dose (UB-04 Billing)

Blue Cross and Blue Shield of Kansas (BCBSKS) continues to monitor COVID-19 and the changes with billing new codes. The following new codes will be reimbursed as follows: <table> <tbody> <tr> <td> HCPCS Code </td> <td> Nomenclature </td> <td> MAP'd like: </td> <td> Effective Date </td> </tr> <tr> <td> 0004A </td> <td> IMMUNIZATION ADMINISTRATION BY INTRAMUSCULAR INJECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, MRNA-LNP, SPIKE PROTEIN, PRESERVATIVE FREE, 30 MCG/0.3 ML DOSAGE, DILUENT RECONSTITUTED; BOOSTER DOSE </td> <td> 0001A 0002A 0003A </td> <td> 09/03/2021 </td> </tr> <tr> <td> 0034A </td> <td> IMMUNIZATION ADMINISTRATION BY INTRAMUSCULAR INJECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, DNA, SPIKE PROTEIN, ADENOVIRUS TYPE 26 (AD26) VECTOR, PRESERVATIVE FREE, 5X1010 VIRAL PARTICLES/0.5 ML DOSAGE - BOOSTER DOSE </td> <td> 0001A 0002A 0003A </td> <td> 10/20/2021 </td> </tr> <tr> <td> 0064A </td> <td> IMMUNIZATION ADMINISTRATION BY INTRAMUSCULAR INJECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, MRNA-LNP, SPIKE PROTEIN, PRESERVATIVE FREE, 50 MCG/0.25 ML DOSAGE, BOOSTER DOSE </td> <td> 0001A 0002A 0003A </td> <td> 09/03/2021 </td> </tr> <tr> <td> 91306 </td> <td> SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) VACCINE, MRNA-LNP, SPIKE PROTEIN, PRESERVATIVE FREE, 100 MCG/0.5 ML DOSAGE, FOR INTRAMUSCULAR USE </td> <td> 91300 91301 </td> <td> 09/03/2021 </td> </tr> </tbody> </table> If you have any questions regarding this newsletter, please contact your <a href="/providers/institutional/contact-us">BCBSKS Institutional Relations provider consultant</a>.